NASDAQ
Disc Medicine, Inc. (IRON) Discusses ASH Conference Data Updates and Portfolio Progress Including Anemia and Iron Restriction Programs Transcript...
WATERTOWN, Mass., Dec. 06, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel ...
Disc Medicine, Inc. ( IRON ) Jefferies London Healthcare Conference 2025 November 19, 2025 9:00 AM EST Company Participants John Quisel - CEO, President & Director Conference Call Participants Jiale S...
Bain Capital completely exited its position in Disc Medicine stock during the third quarter...
Disc Medicine, Inc. ( IRON ) Stifel 2025 Healthcare Conference November 13, 2025 8:40 AM EST Company Participants Jonathan Yu - Chief Opearating Officer Conference Call Participants Stephen Willey - S...
Shares of Ironveld Plc (LON: IRON - Get Free Report) rose 10% during trading on Friday. The company traded as high as GBX 0.06 and last traded at GBX 0.06. Approximately 259,699,203 shares changed han...
WATERTOWN, Mass., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel ...
Shares of Disc Medicine, Inc. (NASDAQ: IRON - Get Free Report) have received an average recommendation of "Moderate Buy" from the eleven brokerages that are presently covering the firm, MarketBeat rep...
Does Disc Medicine, Inc. (IRON) have what it takes to be a top stock pick for momentum investors? Let's find out....
The consensus price target hints at a 26.3% upside potential for Disc Medicine, Inc. (IRON). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnin...
No price data available for this timeframe.